Sepsis is a potentially life-threatening complication due to presence of both infection and the systemic inflammatory response; it is caused by overwhelming immune response to infection. Sepsis is treated as a medical emergency, and severe case of sepsis may lead to septic shock, in which blood pressure reduces dramatically. It is estimated that the sepsis and septic shock treatment market will show significant market growth over the forecast period primarily due to growing number of target population, higher number of unmet needs, advancement in sepsis assessment techniques and presence of novel pipeline therapeutics.
The report titled “Sepsis and Septic Shock Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” included in-depth analysis of sepsis and septic shock market for period of 2015 to 2025. This market report includes detailed study of market segments based on treatment type such as antimicrobial therapy (antibacterial drugs, antiviral drugs and antifungal drugs) and adjunctive therapy (mechanical ventilation, vasopressor therapy, fluid therapy, corticosteroids, blood transfusion, dialysis and insulin therapy).
For the purpose of the geographical study, the global sepsis and septic shock treatment market is categorized on the basis of key regional market such as North America, Europe, Latin America, Asia Pacific and Middle East and Africa. For further regional and country level analysis, sepsis and septic shock treatment market is categorized into United States, Canada, Germany, United Kingdom, rest of Europe, Brazil, Mexico, Rest of LATAM, China, Japan, rest of APAC, GCC and rest of MEA.
Along with statistical information, in-depth qualitative information assessment tools are included in this study for better understanding about general market situation and future prospects. For understanding of ongoing trend of market and future market scenario, detail information regarding pipeline analysis, market drivers, challenges and opportunities in the global sepsis and septic shock treatment market are included in report. To provide in-depth information about the key players involve in sepsis and septic shock R&D activities, attractive investment proposition and company profiling section are also included in this report.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Sepsis and Septic Shock Treatment Market Portraiture
2.1.1. Global Sepsis and Septic Shock Treatment Market, by Treatment Type, 2016
2.1.2. Global Sepsis and Septic Shock Treatment Market, by Geography, 2016
Chapter 3. Sepsis and Septic Shock Treatment: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography, 2016
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Pipeline Analysis of Sepsis and Septic Shock Treatment Drugs
4.1. Overview
4.2. Tabular Representation of Sepsis and Septic Shock Pipeline Drugs
Chapter 5. Global Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Antimicrobial Therapy
5.2.1. Antibacterial Drugs
5.2.1.1. Cephalosporins
5.2.1.2. Macrolides
5.2.1.3. Aminoglycosides
5.2.1.4. Penicillins
5.2.1.5. Lincosamides
5.2.1.6. Quinolones
5.2.1.7. Sulfonamides
5.2.1.8. Glycopeptides
5.2.1.9. Other
5.2.2. Antiviral Drugs
5.2.3. Antifungal Drugs
5.3. Adjunctive Therapy
5.3.1. Mechanical ventilation
5.3.2. Vasopressor therapy
5.3.3. Fluid Therapy
5.3.4. Corticosteroids
5.3.5. Blood transfusion
5.3.6. Dialysis
5.3.7. Insulin Therapy
Chapter 6. Global Sepsis and Septic Shock Treatment Market, by Geography, 2015 – 2025
6.1. Overview
6.2. North America Sepsis and Septic Shock Treatment Market Analysis, 2015 – 2025
6.2.1. North America Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
6.2.2.1. U.S.
6.2.2.2. Canada
6.3. Europe Sepsis and Septic Shock Treatment Market Analysis, 2015 – 2025
6.3.1. Europe Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
6.3.2.1. U.K.
6.3.2.2. Germany
6.3.2.3. Rest of Europe
6.4. Asia Pacific Sepsis and Septic Shock Treatment Market Analysis , 2015 – 2025
6.4.1. Asia Pacific Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
6.4.2.1. China
6.4.2.2. Japan
6.4.2.3. Rest of APAC
6.5. Latin America Sepsis and Septic Shock Treatment Market Analysis , 2015 – 2025
6.5.1. Latin America Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
6.5.2.1. Brazil
6.5.2.2. Mexico
6.5.2.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Sepsis and Septic Shock Treatment Market Analysis, 2015 – 2025
6.6.1. MEA Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Sepsis and Septic Shock Treatment Market, by Region, 2015 – 2025 (US$ Mn)
6.6.2.1. GCC
6.6.2.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Adrenomed AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Treatment Type Portfolio
7.1.4. Key Developments
7.2. Altor BioScience Corporation
7.3. Asahi Kasei Pharma
7.4. Boehringer Ingelheim GmbH
7.5. Bristol-Myers Squibb
7.6. InflaRx GmbH
7.7. Inotrem SA
7.8. Pfizer Inc.
7.9. Other Notable Players
List Of Table :
TABLE 1 Global Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Antimicrobial Therapy Market for Sepsis and Septic Shock Treatment, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 3 Global Antibacterial Therapy Market for Sepsis and Septic Shock Treatment, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 4 North America Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 9 Asia Pacific Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 11 Latin America Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Middle East and Africa Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 13 Middle East and Africa Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 14 Adrenomed AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Altor BioScience Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Asahi Kasei Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Bristol-Myers Squibb: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 InflaRx GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Inotrem SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
List Of Figures :
FIG. 1 Sepsis and Septic Shock Treatment: Market Segmentation
FIG. 2 Global Sepsis and Septic Shock Treatment Market, by Treatment Type, 2016 (US$ Mn)
FIG. 3 Global Sepsis and Septic Shock Treatment Market, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Cephalosporins Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 7 Global Macrolides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 8 Global Aminoglycosides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 9 Global Penicillins Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 10 Global Lincosamides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 11 Global Quinolones Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 12 Global Sulfonamides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 13 Global Glycopeptides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 14 Global Other Antibacterial Drugs Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 15 Global Antiviral Drugs Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 16 Global Antifungal Drugs Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 17 Global Mechanical ventilation Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 18 Global Vasopressor therapy Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 19 Global Fluid Therapy Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 20 Global Corticosteroids Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 21 Global Blood Transfusion Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 22 Global Dialysis Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 23 Global Insulin Therapy Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 24 U.S. Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 25 Canada Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 26 U.K. Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 27 Germany Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest of Europe Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 29 Japan Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 30 China Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest of Asia Pacific Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 32 Brazil Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 33 Mexico Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest of Latin America Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 35 GCC Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 36 Rest of Middle East and Africa Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
Based on treatment types, the global sepsis and septic shock treatment market is segmented as follows:
It is expected that the global sepsis and septic shock treatment market will show lucrative market growth majorly due to rising number of affected population, technological development in sepsis assessment, increase in research and development for developing sepsis treatments and expected launch of novel pipeline molecules over the forecast period. It is studied that antibacterial drugs among the antimicrobial therapies is the major revenue generating segment and anticipated to show fastest market growth during forecast period. Because bacteria such as Staphylococcus and Escherichia coli are the most common causes of sepsis. Furthermore, expected launch of pipeline drugs such as MDX 1105, CYT-107, ALT-836, LB-1148, IFX-1 etc. would assist market growth of sepsis drugs during forecast period. Broad-spectrum antibiotics are preferably used to initiate treatment as these are effective against a variety of bacteria. Currently, there is no approved regimen specific to treatment of sepsis but antimicrobials and adjunctive therapies are used to treat and management of sepsis. Previously, activated drotrecogin alfa (Xigris) was approved for sepsis, but has been voluntarily withdrawn by Eli Lilly in 2011 due to lack of efficacy.
For the purpose of this study, the global sepsis and septic shock treatment market is categorized into:
Sepsis is a clinical condition caused by overwhelming inflammatory response to infection leading to multiple organ dysfunction. According to the Centers for Disease Control and Prevention (CDC), each year, more than 1.5 million people are affected with sepsis in the United States; 250,000 Americans die every year due to sepsis. It is observed that among the considered geographical markets, North America is currently dominating the global sepsis and septic shock treatment market and the growth is mainly driven by United States. Early diagnosis of disease, availability of developed techniques for sepsis assessment, wide accessibility to therapeutics, favorable government reimbursement policies, higher cost of therapeutics and well developed healthcare infrastructure are the important factors that are favoring the market dominance of North America. On the other hand, sepsis and septic shock treatment market in Asia Pacific will show the fastest market growth over the forecast period due to developing healthcare infrastructure, rising number of affected population and increasing penetration of key players in emerging countries such as China and India.
